Skip to content
[P]pubcas
🌐 English
EnglishEnglish简体中文Simplified Chinese繁體中文Traditional ChineseEspañolSpanishFrançaisFrenchDeutschGermanPortuguêsPortugueseРусскийRussianالعربيةArabic日本語Japanese한국어KoreanItalianoItalianNederlandsDutchPolskiPolishTürkçeTurkishTiếng ViệtVietnameseไทยThaiBahasa IndonesiaIndonesianBahasa MelayuMalayहिन्दीHindiবাংলাBengaliاردوUrduفارسیPersianעבריתHebrewУкраїнськаUkrainianRomânăRomanianČeštinaCzechSlovenčinaSlovakMagyarHungarianΕλληνικάGreekБългарскиBulgarianSvenskaSwedishDanskDanishNorsk bokmålNorwegian BokmalSuomiFinnishEestiEstonianLatviešuLatvianLietuviųLithuanianSlovenščinaSlovenianHrvatskiCroatianСрпскиSerbianBosanskiBosnianМакедонскиMacedonianShqipAlbanianAzərbaycanAzerbaijaniქართულიGeorgianՀայերենArmenianҚазақшаKazakhOʻzbekchaUzbekКыргызчаKyrgyzТоҷикӣTajikTürkmençeTurkmenМонголMongolianनेपालीNepaliසිංහලSinhalaதமிழ்TamilతెలుగుTeluguमराठीMarathiગુજરાતીGujaratiಕನ್ನಡKannadaമലയാളംMalayalamਪੰਜਾਬੀPunjabiଓଡ଼ିଆOdiaঅসমীয়াAssameseမြန်မာBurmeseខ្មែរKhmerລາວLaoFilipinoFilipinoKiswahiliSwahiliAfrikaansAfrikaansአማርኛAmharicHausaHausaYorùbáYorubaIgboIgboisiZuluZuluisiXhosaXhosaSoomaaliSomaliMalagasyMalagasyKinyarwandaKinyarwandaChiShonaShonaChichewaChichewaپښتوPashtoسنڌيSindhiKurdîKurdish KurmanjiБеларускаяBelarusianÍslenskaIcelandicGaeilgeIrishCymraegWelshMaltiMalteseEuskaraBasqueCatalàCatalanGalegoGalicianLëtzebuergeschLuxembourgishBasa JawaJavaneseBasa SundaSundaneseKreyòl ayisyenHaitian CreoleMāoriMaoriGagana SamoaSamoanLatinaLatinEsperantoEsperanto
Independent chemical reference Compare
Chemical substance record

(R)-lisofylline

100324-81-0C13H20N4O3280.328 g/mol

A 1-(5-hydroxyhexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione that has (R)-configuration. A synthetic small molecule which was under development for the treatment of type 1 diabetes mellitus. — ChEBI

Quick answers Safety references

Quick answers about (R)-lisofylline

Identity · formula · mass

What is (R)-lisofylline, CAS 100324-81-0?

(R)-lisofylline is the substance linked to CAS 100324-81-0 in ChEBI entry CHEBI:143527. The reported formula is C13H20N4O3. Confirm the structural identifiers when distinguishing salts, hydrates, isomers or isotopically labelled materials.

Source ↗

What is the molar mass of (R)-lisofylline?

The ChEBI-reported molar mass is 280.328 g/mol for formula C13H20N4O3. Its source-reported monoisotopic mass is 280.15354 Da; that uses a specific isotope composition and is a different quantity.

Source ↗

Which PubChem properties are available for (R)-lisofylline?

CID 501254 is connected to this record by an exact InChIKey match. PubChem reports exact mass 280.15354051 Da. computed XLogP 0.7. Values and source conventions are shown separately in the property tables below.

Source ↗

Identity & molecular properties

Source-linked values
CAS number100324-81-0ChEBI ↗
Chemical formulaC13H20N4O3ChEBI ↗
Molar mass280.328 g/molChEBI ↗
Monoisotopic mass280.15354 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:143527ChEBI ↗

PubChem molecular properties

PubChem
Molar mass280.32 g/molPubChem ↗
Exact mass280.15354051 DaPubChem ↗
Computed XLogP0.7PubChem ↗
Topological polar surface area (Ų)78.7PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds5PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
(R)-lisofylline
1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione
NSMXQKNUPPXBRG-SECBINFHSA-N
C[C@@H](O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1

Names & synonyms

1-[(5R)-5-hydroxyhexyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dionelisofilinalisofyllinelisofyllinumProTec

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

hypoglycemic agentimmunomodulatoranti-inflammatory agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00356725 mol

Uses 280.328 g/mol from ChEBI; basis: the substance and formula represented in this record. No purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 13 atoms
55.70%
N
Nitrogen · 4 atoms
19.99%
O
Oxygen · 3 atoms
17.12%
H
Hydrogen · 20 atoms
7.19%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Effects of lisofylline on hyperoxia-induced lung injury. ↗The American journal of physiology · 1999 May · PMID 10330034
WO2009099582 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:143527

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 501254 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.